We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Impax Reverse Payment About Dodging Competition, FTC Told

Law360, Washington (October 11, 2018, 10:03 PM EDT) -- Federal Trade Commission staff attorneys urged the commission in oral arguments Thursday to revive a pay-for-delay case against Impax over the opioid pain medication Opana ER, arguing that brandmaker Endo Pharmaceuticals...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.